Učitavanje...
Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin
OBJECTIVES: To evaluate the proportion of children with lopinavir C(min) ≥1 mg/L when receiving a novel 8-hourly lopinavir/ritonavir dosing strategy during rifampicin co-treatment. METHODS: HIV-infected children on lopinavir/ritonavir and rifampicin were enrolled in a prospective pharmacokinetic stu...
Spremljeno u:
| Izdano u: | J Antimicrob Chemother |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640304/ https://ncbi.nlm.nih.gov/pubmed/31081020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz171 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|